Hindustan Times, Mumbai | By Swaraj Singh Dhanjal
PUBLISHED ON APR 30, 2020 05:55 AM IST
The two multinational giants had announced the all-share deal worth ₹31,700 crore in December 2018. Bloomberg first reported on Wednesday that GSK was in discussions with its advisers on when to launch the transaction.
Bloomberg | By Shruti Srivastava
UPDATED ON JUL 27, 2020 12:43 AM IST
Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.
Bloomberg | By Ari Altstedter, Bloomberg
PUBLISHED ON MAR 27, 2018 05:32 PM IST
Proceeds from a potential sale of GlaxoSmithKline Consumer Healthcare Ltd would be used to finance Glaxo’s $13 billion buyout of Novartis AG’s stake in their consumer-health joint venture.
James Paton, Bloomberg | By HT Correspondent
UPDATED ON MAR 27, 2018 03:07 PM IST
Glaxo’s boss has said that buying the Novartis holding, whose products include Sensodyne toothpaste, Theraflu cold medicine and Panadol pain relievers, would strengthen its consumer business.